Literature DB >> 29090415

Prognostic effect of neutrophil-lymphocyte ratio during concurrrent chemo-radiotherapy period in glioblastoma patients who did not receive dexamethasone.

Kadri Altundag1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29090415     DOI： 10.1007/s11060-017-2645-z

Source DB:  PubMed          Journal:  J Neurooncol        ISSN： 0167-594X            Impact factor:   4.130


× No keyword cloud information.
  2 in total

1.  Neutrophil-lymphocyte ratio dynamics during concurrent chemo-radiotherapy for glioblastoma is an independent predictor for overall survival.

Authors:  Matthew Mason; Catherine Maurice; Mairead G McNamara; Minh Thi Tieu; Zarnie Lwin; Barbara-Ann Millar; Cynthia Menard; Normand Laperriere; Michael Milosevic; Eshetu G Atenafu; Warren Mason; Caroline Chung
Journal:  J Neurooncol       Date:  2017-03-22       Impact factor: 4.130

2.  Dexamethasone inhibits apoptosis of human neutrophils induced by reactive oxygen species.

Authors:  Lina M Ruiz; Gabriel Bedoya; James Salazar; Diana García de O; Pablo J Patiño
Journal:  Inflammation       Date:  2002-10       Impact factor: 4.092
  2 in total
  1 in total

1.  Research Supporting a Pilot Study of Metronomic Dapsone during Glioblastoma Chemoirradiation.

Authors:  Richard E Kast
Journal:  Med Sci (Basel)       Date:  2021-02-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.